2021
DOI: 10.1016/j.anndiagpath.2021.151722
|View full text |Cite
|
Sign up to set email alerts
|

Impact of RASSF1A gene methylation on clinico-pathological features of tumor and non-tumor tissue of breast cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
15
0

Year Published

2021
2021
2025
2025

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 17 publications
(16 citation statements)
references
References 13 publications
1
15
0
Order By: Relevance
“…Previous studies regarding the Mst2 kinase reported that phosphorylation of Akt prevents Rassf1A binding and decreases Mst2 kinase activity (138,139). Rassf1A is a Hippo signaling pathway regulator that is highly silenced in human gastric (130), esophageal (140), lung (141), breast (142) and liver cancer (143). Akt signaling inhibition using a PI3K inhibitor can demethylate the promoter of Rassf1A and increase the protein expression levels of rassf1a, resulting in Hippo signaling pathway activation (144,145).…”
Section: Discussionmentioning
confidence: 99%
“…Previous studies regarding the Mst2 kinase reported that phosphorylation of Akt prevents Rassf1A binding and decreases Mst2 kinase activity (138,139). Rassf1A is a Hippo signaling pathway regulator that is highly silenced in human gastric (130), esophageal (140), lung (141), breast (142) and liver cancer (143). Akt signaling inhibition using a PI3K inhibitor can demethylate the promoter of Rassf1A and increase the protein expression levels of rassf1a, resulting in Hippo signaling pathway activation (144,145).…”
Section: Discussionmentioning
confidence: 99%
“…Although RASSF1A remains expressed in cancer, concentrations of RASSF1A protein above or below its optimal expression threshold can disrupt signal transduction and lead to malignant transformation [ 31 ]. Promoter methylation of RASSF1A was also found to be significantly correlated with tumor size and histological grade of BC [ 33 ]. Therefore, we hypothesized that hypermethylation of RASSF1A promoter disrupts normal body signal transduction, leading to tumor recurrence, and metastasis and poorer clinical outcomes.…”
Section: Discussionmentioning
confidence: 99%
“…You may be limited in your activities depending on the extent and severity of the disease. To prevent future infection, your healthcare professional may recommend that you take treatment for a long time [12,13,14].…”
Section: Discussionmentioning
confidence: 99%
“…Brainstem gliomas have an incidence rate of 1.4 percent of intracranial tumors in the child age group and comprise 28.7 percent of posterior fossa tumors in the child age group. The exact incidence of brainstem glioma is not known due to low biopsy of tissue and resection rates of these lesions [15,16,17].…”
Section: Discussionmentioning
confidence: 99%